Return on Assets (ROA)
since 2005
Calculation
Amgen Inc., ROA, long-term trends, calculation
| ROA | = | 100 | × | Net income1 | ÷ | Total assets1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 4.45% | = | 100 | × | 4,090) | ÷ | 91,839) |
| Dec 31, 2023 | 6.91% | = | 100 | × | 6,717) | ÷ | 97,154) |
| Dec 31, 2022 | 10.06% | = | 100 | × | 6,552) | ÷ | 65,121) |
| Dec 31, 2021 | 9.63% | = | 100 | × | 5,893) | ÷ | 61,165) |
| Dec 31, 2020 | 11.54% | = | 100 | × | 7,264) | ÷ | 62,948) |
| Dec 31, 2019 | 13.13% | = | 100 | × | 7,842) | ÷ | 59,707) |
| Dec 31, 2018 | 12.64% | = | 100 | × | 8,394) | ÷ | 66,416) |
| Dec 31, 2017 | 2.48% | = | 100 | × | 1,979) | ÷ | 79,954) |
| Dec 31, 2016 | 9.95% | = | 100 | × | 7,722) | ÷ | 77,626) |
| Dec 31, 2015 | 9.69% | = | 100 | × | 6,939) | ÷ | 71,576) |
| Dec 31, 2014 | 7.47% | = | 100 | × | 5,158) | ÷ | 69,009) |
| Dec 31, 2013 | 7.68% | = | 100 | × | 5,081) | ÷ | 66,125) |
| Dec 31, 2012 | 8.00% | = | 100 | × | 4,345) | ÷ | 54,298) |
| Dec 31, 2011 | 7.54% | = | 100 | × | 3,683) | ÷ | 48,871) |
| Dec 31, 2010 | 10.64% | = | 100 | × | 4,627) | ÷ | 43,486) |
| Dec 31, 2009 | 11.62% | = | 100 | × | 4,605) | ÷ | 39,629) |
| Dec 31, 2008 | 11.51% | = | 100 | × | 4,196) | ÷ | 36,443) |
| Dec 31, 2007 | 9.14% | = | 100 | × | 3,166) | ÷ | 34,639) |
| Dec 31, 2006 | 8.73% | = | 100 | × | 2,950) | ÷ | 33,788) |
| Dec 31, 2005 | 12.54% | = | 100 | × | 3,674) | ÷ | 29,297) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
The analysis of the financial data over the reported periods reveals several notable trends and fluctuations in net income, total assets, and return on assets (ROA).
- Net Income
- Net income experienced variability across the years. Initially, the figure increased from 3674 million US dollars in 2005 to a peak of 7722 million in 2016, with some fluctuations along the way. There was a significant decline in 2017 to 1979 million, followed by a steep recovery to 8394 million in 2018, which represents the highest value in the series. Afterward, net income gradually decreased to 4090 million by 2024, indicating volatility and a downward trajectory in the most recent years.
- Total Assets
- Total assets showed a steady upward trend from 29297 million US dollars in 2005 to a peak of 79954 million in 2017. During the years following, there was a marked decline to 59707 million in 2019, followed by a moderate recovery and another upward spike reaching 97154 million in 2023. This peak is followed by a decrease to 91839 million in 2024. Overall, total assets increased substantially over the entire period, reflecting significant growth with intermittent periods of contraction.
- Return on Assets (ROA)
- The ROA percentage, which measures profitability relative to assets, showed considerable fluctuation. From a high of 12.54% in 2005, it dropped to a low of 7.54% in 2011. The ratio improved to around 9.95% in 2016 before falling sharply to 2.48% in 2017, coinciding with the net income drop. The ROA rebounded to 13.13% in 2019, the highest value for the entire period, indicating exceptional asset efficiency that year. However, the ROA decreased again thereafter, falling to 4.45% by 2024. This pattern indicates variable asset profitability with peaks in 2005, 2019, and a decline in recent years.
In summary, while total assets generally grew over the period under consideration, net income and ROA exhibited notable volatility with periods of both strong profitability and decline. The fluctuations in ROA and net income in particular suggest varying operational performance and efficiency in leveraging assets over time.
Comparison to Competitors
Amgen Inc., ROA, long-term trends, comparison to competitors
| Amgen Inc. | AbbVie Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 4.45% | 3.17% | -9.66% | 5.03% | 13.45% | 0.81% | 7.81% | 14.62% | 3.76% | 11.69% | 6.51% | -2.38% |
| Dec 31, 2023 | 6.91% | 3.61% | 8.43% | 5.64% | 8.19% | 9.12% | 20.98% | 0.34% | 0.94% | 11.95% | 6.07% | 15.92% |
| Dec 31, 2022 | 10.06% | 8.53% | 6.53% | 8.55% | 12.62% | 7.27% | 9.57% | 13.30% | 15.91% | 14.85% | 7.15% | 18.30% |
| Dec 31, 2021 | 9.63% | 7.88% | 6.40% | 7.73% | 11.44% | 9.16% | 11.47% | 12.35% | 12.11% | 31.75% | 8.12% | 17.44% |
| Dec 31, 2020 | 11.54% | 3.07% | -7.61% | 4.79% | 13.28% | 0.18% | 8.41% | 7.72% | 6.23% | 20.47% | 9.23% | 23.07% |
| Dec 31, 2019 | 13.13% | 8.84% | 2.65% | 4.85% | 21.17% | 8.74% | 9.59% | 11.66% | 9.72% | 14.29% | 6.33% | 14.15% |
| Dec 31, 2018 | 12.64% | 9.58% | 14.06% | 5.54% | 7.36% | 8.57% | 10.00% | 7.53% | 7.00% | 20.83% | 5.22% | 33.57% |
| Dec 31, 2017 | 2.48% | 7.50% | 3.00% | 5.34% | -0.45% | 6.58% | 0.83% | 2.72% | 12.40% | 13.67% | 3.93% | 7.43% |
| Dec 31, 2016 | 9.95% | 9.01% | 13.22% | 5.64% | 7.05% | 23.70% | 11.71% | 4.11% | 4.20% | 12.84% | 4.40% | -3.87% |
| Dec 31, 2015 | 9.69% | 9.70% | 4.93% | 6.96% | 6.77% | 34.93% | 11.55% | 4.36% | 4.16% | 11.34% | 4.83% | -22.26% |
| Dec 31, 2014 | 7.47% | 6.44% | 5.94% | 7.02% | 6.43% | 34.91% | 12.45% | 12.12% | 5.40% | 8.99% | 4.42% | -31.63% |
| Dec 31, 2013 | 7.68% | 14.14% | 6.64% | 7.77% | 13.29% | 13.67% | 10.42% | 4.17% | 12.78% | 14.38% | 4.00% | -19.19% |
| Dec 31, 2012 | 8.00% | 19.53% | 5.46% | 7.26% | 11.89% | 12.20% | 8.94% | 5.81% | 7.84% | 36.06% | 4.29% | -3.88% |
| Dec 31, 2011 | 7.54% | — | 11.25% | 7.25% | 12.92% | 16.20% | 8.51% | 5.97% | 5.32% | -16.75% | 4.96% | 1.34% |
| Dec 31, 2010 | 10.64% | — | 9.98% | 8.07% | 16.35% | 25.03% | 12.96% | 0.81% | 4.23% | -9.59% | 4.85% | -43.74% |
| Dec 31, 2009 | 11.62% | — | 34.22% | 5.88% | 15.76% | 27.18% | 12.95% | 11.51% | 4.05% | -9.15% | 3.93% | -32.84% |
| Dec 31, 2008 | 11.51% | — | 17.76% | 7.53% | -7.09% | 28.65% | 15.25% | 16.54% | 7.29% | -12.34% | 4.71% | -46.90% |
| Dec 31, 2007 | 9.14% | — | 8.27% | 7.84% | 11.02% | 27.68% | 13.06% | 6.77% | 7.07% | -11.28% | 3.59% | -65.05% |
| Dec 31, 2006 | 8.73% | — | 6.20% | 8.72% | 12.13% | -29.12% | 15.67% | 9.95% | 16.84% | -17.49% | 0.79% | -22.45% |
| Dec 31, 2005 | 12.54% | — | 10.66% | 9.80% | 8.05% | 21.62% | 17.94% | 10.33% | 6.88% | -22.54% | 5.25% | -37.05% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Amgen Inc., ROA, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Amgen Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2024 | 4.45% | 5.30% |
| Dec 31, 2023 | 6.91% | 7.25% |
| Dec 31, 2022 | 10.06% | 10.67% |
| Dec 31, 2021 | 9.63% | 10.42% |
| Dec 31, 2020 | 11.54% | 5.45% |
| Dec 31, 2019 | 13.13% | 9.02% |
| Dec 31, 2018 | 12.64% | 8.97% |
| Dec 31, 2017 | 2.48% | 5.28% |
| Dec 31, 2016 | 9.95% | 8.61% |
| Dec 31, 2015 | 9.69% | 8.93% |
| Dec 31, 2014 | 7.47% | 9.45% |
| Dec 31, 2013 | 7.68% | 9.46% |
| Dec 31, 2012 | 8.00% | 8.30% |
| Dec 31, 2011 | 7.54% | 7.30% |
| Dec 31, 2010 | 10.64% | 7.07% |
| Dec 31, 2009 | 11.62% | 10.02% |
| Dec 31, 2008 | 11.51% | 10.37% |
| Dec 31, 2007 | 9.14% | 8.86% |
| Dec 31, 2006 | 8.73% | 11.91% |
| Dec 31, 2005 | 12.54% | 10.42% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Amgen Inc., ROA, long-term trends, comparison to industry (health care)
| Amgen Inc. | Health Care | |
|---|---|---|
| Dec 31, 2024 | 4.45% | 5.25% |
| Dec 31, 2023 | 6.91% | 6.71% |
| Dec 31, 2022 | 10.06% | 8.71% |
| Dec 31, 2021 | 9.63% | 8.70% |
| Dec 31, 2020 | 11.54% | 5.45% |
| Dec 31, 2019 | 13.13% | 7.57% |
| Dec 31, 2018 | 12.64% | 6.72% |
| Dec 31, 2017 | 2.48% | 5.31% |
| Dec 31, 2016 | 9.95% | 7.18% |
| Dec 31, 2015 | 9.69% | 7.54% |
| Dec 31, 2014 | 7.47% | 8.41% |
| Dec 31, 2013 | 7.68% | 8.58% |
| Dec 31, 2012 | 8.00% | 7.94% |
| Dec 31, 2011 | 7.54% | 7.22% |
| Dec 31, 2010 | 10.64% | 7.11% |
| Dec 31, 2009 | 11.62% | 9.45% |
| Dec 31, 2008 | 11.51% | 9.08% |
| Dec 31, 2007 | 9.14% | 8.51% |
| Dec 31, 2006 | 8.73% | 10.37% |
| Dec 31, 2005 | 12.54% | 9.62% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).